Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma

By Dogan Erkan  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1436-1437

Humana Press, Inc

Access to resources Recommend Favorite

Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study

By Shinsako Keiko   Mizuno Tomoyuki   Terada Tomohiro   Watanabe Jun   Kamba Tomomi   Nakamura Eijiro   Ogawa Osamu   Inui Ken-ichi  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 512-514

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report

By                      

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1633-1636

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third or fourthline treatment: A retrospective multicenter experience

By                                    

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 605-611

Spandidos Publications

Access to resources Recommend Favorite

Appropriate management of cutaneous adverse events maximizes compliance with sorafenib treatment: a single-center experience

By Scandurra Giuseppa   Aiello Rosa Anna   Alì Marco   Taibi Eleonora   Sanò Maria Vita   Todaro Francesco Maurizio   La Rocca Rosaria   Licciardello Paolo   Caruso Michele  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 609-615

Future Medicine

Access to resources Recommend Favorite